Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 6/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL480692 | 0.88 | CA1 (0.61) | DHFR | |
| SCHEMBL4685928 | 0.86 | DHFR (0.61) | DHFR | |
| SCHEMBL11664759 | 0.84 | DHFR (0.78) | DHFR | |
| SCHEMBL4814896 | 0.80 | DHFR (0.70) | DHFR | |
| SCHEMBL4695063 | 0.79 | DHFR (0.62) | DHFR | |
| SCHEMBL13598112 | 0.78 | DHFR (0.57) | DHFR | |
| SCHEMBL14100003 | 0.77 | DHFR (0.62) | DHFR | |
| SCHEMBL5860508 | 0.77 | DHFR (0.67) | DHFR | |
| SCHEMBL11632935 | 0.77 | DHFR (0.62) | DHFR | |
| SCHEMBL11630631 | 0.75 | DHFR (0.56) | DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2002541144-A | — | — | 2002-12-03 | — | — | JP | claimed |
| EP-1154997-A4 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF | DANA FARBER CANCER INST INC (US) | 2002-11-04 | — | — | EP | claimed |
| EP-1154997-A1 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2001-11-21 | — | — | EP | claimed |
| WO-2000059884-A1 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2000-10-12 | — | — | WO | claimed |
| US-7056911-B1 | Dibenz[B,F]azepine compounds, pharmaceutical compositions comprising same and methods of use thereof | DANA-FARBER CANCER INSTITUTE (US) | 2006-06-06 | — | — | US | disclosed |
| EP-1154997-A4 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF | DANA FARBER CANCER INST INC (US) | 2002-11-04 | — | — | EP | disclosed |
| EP-1154997-A1 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000059884-A1 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2000-10-12 | — | — | WO | disclosed |